Chemcial Structure (Ertapenem 01)
Ertapenem Injection
Product Images NDC 44647-051
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ertapenem (NDC 44647-051). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Savior Lifetec Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Vail Label (Ertapenem 02)
Ertapenem is a medication used for intravenous or intramuscular use. Each vial contains 1,046 grams ertapenem sodium, equivalent to 1 gram ertapenem. It should be stored below 25°C (77°F) before constitution. Inactive ingredients include sodium bicarbonate and sodium hydroxide. It is manufactured by Savior Lifetec Corporation in Taiwan and distributed by an unspecified company. Dosage and administration should be followed as per accompanying prescribing information. Lot number and expiration date are also included.*
Carton Label (Ertapenem 03)
This is a description of a medication called Ertapenem for Injection, which is intended for intravenous or intramuscular use. The package contains 10 single-dose vials, each containing 1 gram of ertapenem sodium powder. Prior to constitution, the powder should be stored below 25°C. To prepare for use, the powder must be diluted with an approved diluent specified in the package's accompanying prescribing information. The inactive ingredients of the medication include sodium bicarbonate and sodium hydroxide to adjust the pH of the solution to 7.5, and the color of the solution can range from colorless to pale yellow. There is also information about the lot number and expiration date.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
